Eli Lilly participated in Remedium Bio's Series A financing to expand its reach in the area of precision oncology and durable protein therapeutics. This move follows a strong Q2 2026 performance with significant revenue growth. The collaboration aligns with Eli Lilly's focus on innovative drug development. It highlights the company's strategy to diversify beyond its existing metabolic disease portfolio.
Company Information
Company
Eli Lilly
Location
Indianapolis, Indiana, United States
About
Eli Lilly is a global healthcare and pharmaceutical company focused on the discovery, development, and delivery of innovative pharmaceutical medicines, vaccines, and consumer healthcare products. It has a strong presence in the diabetes and obesity market segment and has been actively expanding its manufacturing network to meet the increasing demand for its medicines.
Related People
Suggested for you
5 contacts
Verified contactsSuresh K., Associate Director - Talent Acquisition hidden